Skip to main content

Table 2 Pearson correlations between Pro-C2 levels in axial spondyloarthritis and psoriatic arthritis and clinical parameters

From: Chondrocyte activity is increased in psoriatic arthritis and axial spondyloarthritis

 

axSpA

PsA

 

Total (n = 110)

Treatment-naïve (n = 34)

Currently treated, total (n = 63)

Previously treated (n = 13)

Total (n = 101)

Treatment-naïve (n = 13)

Currently treated, total (n = 76)

Previously treated (n = 12)

Age

ns

ns

ns

ns

ns

r = −0.55

ns

ns

p = −0.051

BMI

ns

ns

ns

ns

ns

r = 0.60

ns

ns

p = 0.032

Disease duration

ns

ns

ns

r = 0.54

ns

r = 0.55

ns

ns

p = 0.030

p = 0.052

ASDAS

ns

r = 0.45

ns

ns

ns

ns

ns

ns

p = 0.008

HAQ

ns

ns

r = 0.47

ns

r = −0.34

ns

r = −0.35

ns

p = 0.010

p = 0.004

p = 0.008

Sex

ns

ns

ns

ns

ns

ns

ns

ns

BASDAI

ns

ns

ns

ns

ns

ns

ns

ns

BASFI

ns

ns

r = −0.30

ns

ns

ns

ns

ns

p = 0.008

SJC68

ns

ns

ns

ns

ns

ns

ns

r = −0.92

p = 0.0001

TJC68

ns

ns

ns

ns

ns

ns

ns

r = −0.89

p = 0.0003

  1. Abbreviations: ASDAS Ankylosing Spondylitis Disease Activity Score, axSpA axial spondyloarthritis, BASDAI Bath Ankylosing Spondylitis Disease Activity Index, BASFI Bath Ankylosing Spondylitis Functional Index, BASMI Bath Ankylosing Spondylitis Metrology Index, BMI body mass index, HAQ Health Assessment Questionnaire, ns not significant, SJC68 68 swollen joint count, TJC68 68 tender joint count